About KRTL Holding Group Inc
- Industry: Pharmaceuticals
- Exchange: OTC MARKETS
- Country: US
- Website: https://www.krtlholding.com/
Frequently Asked Questions
What is the 52-week range for KRTL?
The 52-week high is $0.15 and the 52-week low is $0.0112.
What is the P/E ratio for KRTL?
The P/E ratio data is currently unavailable.
What is the dividend yield for KRTL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Latest KRTL News
KRTL Biotech Expands Regulatory and Partner-Qualification Framework for South American API and Controlled-Substance Pharmaceutical Development
KRTL outlines how expanded regulatory leadership expects to support its developing South American API, botanical, controlled substance, and pharmaceutical strategyLakewood, CO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) (“KRTL” or the “Company”) today outlined how KRTL Biotech Inc. intends to apply its expanded regulatory leadership to the Company’s developing South American pharmaceutical API, controlled-substance, botanical-drug, research, and regulatory-services st
KRTL Biotech Appoints Federal Controlled-Substance Compliance Specialist Justin Abril as President-Designate
Controlled-substance compliance and Schedule I manufacturing specialist brings experience in federal registration, controlled-substance operations, cGMP systems, quota administration, and DEA inspection readinessLakewood, CO, Sept. 14, 2026 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) (“KRTL” or the “Company”) today announced that its wholly owned subsidiary, KRTL Biotech Inc., has appointed Justin Abril as President-Designate and Strategic Regulatory & API Consultant, adding speciali